… A general predisposition for developing a chemotherapy-induced neuropathy has been
observed … prevent or cure chemotherapy-induced neuropathy. ■ Key words Neuropathy · Taxol · …

… discuss the approach to peripheral neuropathy in patients with … Peripheral neuropathies in
cancer patients are most often … so-called chemotherapy-induced peripheral neuropathy (CIPN)…

… One of the most common neuropathies caused by antineoplastic agents is a condition
known as chemotherapy-induced peripheral neuropathy (CIPN) [7]. The prevalence of CIPN is …

Chemotherapy-induced peripheral neuropathy (CIPN) is a major dose limiting side effect of
many commonly used chemotherapeutic agents, including platinum drugs, taxanes, …

… How often do we care for patients at risk for peripheral neuropathies? 3. Describe … peripheral
neuropathies? 5. How can we improve patient education regarding peripheral neuropathies…

… Peripheral neuropathy induced by cancer chemotherapy … Chemotherapy-induced peripheral
neuropathy (CIPN) … Chemotherapy-induced peripheral neuropathy (CIPN) involving sensory …

… Clinically, chemotherapy-induced peripheral neuropathy … severe acute and chronic peripheral
neuropathies. We discuss … the development of peripheral neuropathy, the epidemiology …

… Chemotherapy-induced peripheral neuropathy (CIPN) is one of … management of
chemotherapy-induced peripheral neuropathy, … clinical models of peripheral neuropathy and …

… of peripheral neurotoxicity and neuropathic pain. In the present work we review the role of the
main … in determining the pathogenesis of anticancer drugs-induced peripheral neuropathy. …

Chemotherapy‐induced peripheral neuropathy (CIPN) is a common, dose‐limiting side effect
of many chemotherapeutic agents. Although many therapies have been investigated for …